Prevalence and risk factors associated with chronic kidney disease in a Uygur adult population from Urumqi

被引:0
作者
Chen Lu
Hongjuan Zhao
Gang Xu
Hua Yue
Weili Liu
Kaichun Zhu
Xiaocheng Liu
机构
[1] Huazhong University of Science and Technology,Department of Nephrology, Tongji Hospital, Tongji Medical College
[2] the People’s Hospital of the Xinjiang Uygur Autonomous Region,Department of Nephrology
来源
Journal of Huazhong University of Science and Technology [Medical Sciences] | 2010年 / 30卷
关键词
chronic kidney disease; epidemiology; Uygur;
D O I
暂无
中图分类号
学科分类号
摘要
Evaluating the prevalence of kidney damage according to population-based studies in different communities has been limited in developing countries. We conducted a population-based screening study in Uygur people of Urumqi, aiming to identify the prevalence and associated risk factors of chronic kidney disease (CKD) in Uygur populations. A total of 2576 residents (>18 years) from four districts of Urumqi were interviewed from June 2007 to January 2009 and tested for haematuria, albuminuria and reduced renal function. Associations between age, gender, smoking, diabetes mellitus, hypertension, hyperuricaemia and kidney damage were examined. There were 2576 subjects enrolled in this study. After age correction, the prevalence of albuminuria, haematuria and reduced estimated glomerular filtration rate (eGFR) was 3.58%, 2.26% and 1.03%, respectively. Approximately 5.65% of the sample population had at least one indicator of kidney damage. Age, diabetes mellitus, hypercholesteremia, hyperuricaemia and hyperlipidaemia were independently associated with CKD. In the general Uygur adult population from Urumqi, 5.65% had either proteinuria, haematuria or reduced eGFR, indicating the presence of kidney damage, with an awareness of only 1.05%. The high prevalence and low awareness of CKD in this population suggest an urgent need for CKD prevention programs in Uygur people.
引用
收藏
页码:604 / 610
页数:6
相关论文
共 60 条
[21]  
Cook T.(2006)Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level Am J Kidney Dis 47 51-59
[22]  
Ma Y.C.(2007)undefined MMWR Morb Mortal Wkly Rep 56 1999-2004
[23]  
Zuo L.(undefined)undefined undefined undefined undefined-undefined
[24]  
Chen J.H.(undefined)undefined undefined undefined undefined-undefined
[25]  
Zhang L.(undefined)undefined undefined undefined undefined-undefined
[26]  
Zhang P.(undefined)undefined undefined undefined undefined-undefined
[27]  
Wang F.(undefined)undefined undefined undefined undefined-undefined
[28]  
Clase C.M.(undefined)undefined undefined undefined undefined-undefined
[29]  
Kiberd B.A.(undefined)undefined undefined undefined undefined-undefined
[30]  
Garg A.X.(undefined)undefined undefined undefined undefined-undefined